Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
9.39M
-
Shares change
-
+1.77M
-
Total reported value, excl. options
-
$98.1M
-
Value change
-
+$18.2M
-
Number of buys
-
33
-
Number of sells
-
-6
-
Price
-
$10.44
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2018
47 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q2 2018.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.39M shares
of 27.7M outstanding shares and own 33.92% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), venBio Select Advisor LLC (1.02M shares), Opaleye Management Inc. (945K shares), 683 Capital Management, LLC (867K shares), EVENTIDE ASSET MANAGEMENT, LLC (741K shares), BlackRock Inc. (555K shares), PUTNAM INVESTMENTS LLC (263K shares), ACUTA CAPITAL PARTNERS, LLC (250K shares), STATE STREET CORP (148K shares), and NORTHERN TRUST CORP (101K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.